Evolva Appoints Jutta Heim as Chief Technology Officer
Evolva SA, has expanded its Management team by appointing Jutta Heim as Chief Technology Officer. In her new role, Jutta Heim will lead Evolva’s discovery activities and strengthen the development of our technology platform.
Since 2004, Prof. Jutta Heim served as Chief Scientific Officer at Basilea Pharmaceutica AG, where she had responsibility for all discoveries in the areas of anti-infectives, inflammation and oncology. Before Basilea Jutta worked for 22 years for Ciba-Geigy/Novartis (in Switzerland and the USA), where she was involved in the successful development and launch of anti-thrombotic and fibrinolytic products. She established a molecular genetics department in oncology and became Novartis' Senior Scientific Expert in Molecular Biology and a member of the Research Management Board. Jutta completed her career at Novartis by heading the Novartis Lead Discovery Center with worldwide responsibility. She has published numerous papers in the areas of natural products, recombinant proteins and applied molecular biology. Jutta holds a professorship in Biotechnology at the Biocenter of the University of Basel.
Other news from the department people
